Christof Langer

Title: Christof Langer: Innovator in Immunogenic Composition

Introduction

Christof Langer is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of immunology, particularly with his innovative approaches to immunogenic compositions. His work is aimed at addressing gastrin-dependent diseases, showcasing his commitment to advancing medical science.

Latest Patents

Langer holds a patent for a gastrin peptide immunogenic composition. This invention provides an immunogenic composition that includes a directed adjuvant comprising an anti-CD32 moiety linked to a TLR9 ligand and a first peptidic alpha-helix. Additionally, it features a gastrin-17 peptide immunogen linked to a second peptidic alpha-helix coiled to the first alpha-helix. The peptide immunogen can be human gastrin-17 or its analogs, with potential applications in treating gastrin-dependent diseases. He has 1 patent to his name.

Career Highlights

Christof Langer is associated with Tyg Oncology Ltd., where he continues to develop his innovative ideas. His work is characterized by a strong focus on the medical applications of his inventions, particularly in the realm of immunology.

Collaborations

Langer has collaborated with notable professionals in his field, including Geert Mudde and Paul Christopher Broome. These collaborations have likely contributed to the advancement of his research and the successful development of his patent.

Conclusion

Christof Langer's contributions to immunogenic compositions reflect his dedication to improving medical treatments for gastrin-dependent diseases. His innovative work continues to inspire advancements in the field of immunology.